Competition in the fast-growing pulsed field ablation (PFA) market has intensified with the arrival of Johnson & Johnson’s ...
Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
Over the past year, Haemonetics has reshaped its product portfolio through restructuring and M&A, adding devices used in ...
The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...
Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the initiation of the EMBO-02 clinical study of NeoCastâ„¢ to treat chronic subdural ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...